Skip to main content
. Author manuscript; available in PMC: 2010 May 1.
Published in final edited form as: Hepatology. 2009 May;49(5 Suppl):S166–S173. doi: 10.1002/hep.22899

Table 3. Suggested frequency of monitoring during and after antiviral therapy.

Serum marker On therapy After therapy

HBV DNA Every 12 weeks (every 24 weeks after one year) Every 4 to12 weeks (every 24 to 48 weeks after one year)
HBeAg, anti-HBe Every 24 weeks (If HBeAg positive) Every 4 to 12 weeks (every 24 to 48 weeks after one year)
HBsAg Every 24 to 48 weeks (If HBeAg negative) Every 48 weeks
ALT Every 12 weeks Every 12 weeks
Liver biopsy Not Needed Individualized
Creatinine/Phosphate (ADV/TDF) Every 12 weeks Not needed
CBC (Interferon) Every 4 weeks Not Needed
TSH (Interferon) Every 12 weeks Not needed

Abbreviations: ADV, adefovir; TDF, tenofovir; CBC, complete blood count; TSH, thyroid stimulating hormone